Skip to main content

Quality of life in patients with blepharospasm

Buy Article:

$51.00 plus tax (Refund Policy)

Objectives– Administration of botulinum neurotoxin A (BONT/A) is a common and effective treatment of blepharospasm. There is, however, no information regarding the emotional and social well-being of patients with blepharospasm and patient acceptance of BONT/A therapy. The purpose of this study was to investigate aspects of quality of life of patients with blepharospasm and level of patient satisfaction with treatment. Material and methods– Fifty-one patients with blepharospasm who had been treated with BONT/A for years completed a questionnaire providing information about quality of life. Results– Results revealed reductions in social and emotional well-being of patients but, nonetheless, good acceptance of BONT/A therapy. The positive effects of BONT/A therapy were, however, accompanied by fear of a decreasing effect of BONT/A injections. Conclusion– Although the objective findings following BONT/A injections in the treatment of blepharospasm are appreciated by the patients, their well-being is affected by fears and depression.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: blepharospasm; botulinum toxin; emotional well-being; quality of life; social well-being

Document Type: Short Communication

Affiliations: 1: Department of Neuropsychology, University of Regensburg, Regensburg, Germany, 2: Department of Neurology, University of Würzburg, Würzburg, Germany

Publication date: 2001-01-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more